Jan Leschly
CIK 1204568 · last filed 2018-02-15
Jan Leschly is a corporate insider who has filed 22 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for VXRT, was dated Feb 15, 2018. Across all open-market trades the lifetime net is +$2.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $39.2M across reported positions. 17 SEC filings were submitted jointly with AMERICAN EXPRESS CO.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AXP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
47 HULFISH STREET, SUITE 310
PRINCETON, NJ 08542
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Vaxart, Inc. (VXRT) Delisted | Director | 30,793,670 | $0.32 | $9.85M | $0 | 1 | 2018-02-15 |
| AXP | Director | 120,309 | $325.67 | $39.18M | $2.61M | 14 | 2012-11-21 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-15 | Vaxart, Inc. (VXRT) Delisted | Grant (A) | +30,793,670 | $0 | EDGAR |
| 2012-11-21 | AXP | Mixed | — | $5.4K | EDGAR |
| 2012-05-11 | AXP | Grant (A) | — | $0 | EDGAR |
| 2012-03-02 | AXP | Mixed | — | -$53.9K | EDGAR |
| 2011-05-04 | AXP | Grant (A) | — | $0 | EDGAR |
| 2011-01-27 | AXP | Mixed | — | -$31.8K | EDGAR |
| 2010-04-27 | AXP | Grant (A) | — | $0 | EDGAR |
| 2010-04-26 | AXP | Exer (M) | +3,427 | $146.6K | EDGAR |
| 2009-07-17 | — | Sell (S) | −159,144 | -$1.07M | |
| 2009-07-07 | — | Sell (S) | −76,511 | -$474.5K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.